Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 35 | 2018 | 3769 | 2.970 |
Why?
|
Pseudomonas aeruginosa | 9 | 2024 | 1277 | 1.740 |
Why?
|
Muscle, Skeletal | 17 | 2024 | 4948 | 1.620 |
Why?
|
Pseudomonas Infections | 8 | 2024 | 622 | 1.330 |
Why?
|
Burns | 10 | 2013 | 1882 | 1.290 |
Why?
|
Brain Neoplasms | 20 | 2016 | 9031 | 1.040 |
Why?
|
Acetophenones | 3 | 2024 | 53 | 1.030 |
Why?
|
Robotics | 5 | 2019 | 819 | 0.990 |
Why?
|
Quorum Sensing | 6 | 2024 | 137 | 0.850 |
Why?
|
Adenosine Triphosphate | 8 | 2024 | 1989 | 0.820 |
Why?
|
Magnetic Resonance Imaging | 24 | 2023 | 36426 | 0.820 |
Why?
|
Mitochondria | 11 | 2024 | 3624 | 0.800 |
Why?
|
Drosophila melanogaster | 4 | 2015 | 1712 | 0.680 |
Why?
|
Ion Channels | 3 | 2015 | 1040 | 0.620 |
Why?
|
Mitochondrial Proteins | 3 | 2015 | 976 | 0.570 |
Why?
|
Volatile Organic Compounds | 1 | 2018 | 86 | 0.570 |
Why?
|
Insulin Resistance | 4 | 2015 | 3963 | 0.560 |
Why?
|
Hand Strength | 2 | 2019 | 456 | 0.560 |
Why?
|
Lipid Metabolism | 9 | 2010 | 1902 | 0.510 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 509 | 0.500 |
Why?
|
Citric Acid Cycle | 2 | 2013 | 231 | 0.500 |
Why?
|
Contrast Media | 4 | 2018 | 5311 | 0.490 |
Why?
|
Neuronal Plasticity | 3 | 2013 | 1436 | 0.480 |
Why?
|
Stroke | 5 | 2023 | 9757 | 0.460 |
Why?
|
Mitochondria, Muscle | 2 | 2024 | 172 | 0.450 |
Why?
|
Cerebrovascular Disorders | 2 | 2019 | 1474 | 0.430 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2065 | 0.430 |
Why?
|
Thoracic Injuries | 1 | 2015 | 288 | 0.420 |
Why?
|
Drosophila Proteins | 2 | 2014 | 1699 | 0.420 |
Why?
|
Cachexia | 2 | 2013 | 202 | 0.420 |
Why?
|
Oligopeptides | 3 | 2024 | 1187 | 0.410 |
Why?
|
Glutathione Transferase | 1 | 2014 | 565 | 0.400 |
Why?
|
Apoptosis | 5 | 2016 | 9486 | 0.360 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2491 | 0.350 |
Why?
|
Gene Expression Profiling | 8 | 2012 | 9420 | 0.350 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 343 | 0.340 |
Why?
|
Magnetite Nanoparticles | 1 | 2010 | 318 | 0.320 |
Why?
|
Dextrans | 1 | 2010 | 574 | 0.310 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3778 | 0.310 |
Why?
|
Wound Infection | 1 | 2010 | 246 | 0.310 |
Why?
|
Aspartic Acid | 5 | 2004 | 576 | 0.300 |
Why?
|
Image Enhancement | 1 | 2018 | 2885 | 0.300 |
Why?
|
Glycine | 2 | 2010 | 663 | 0.300 |
Why?
|
Oxidative Stress | 2 | 2016 | 3113 | 0.290 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.280 |
Why?
|
Antioxidants | 2 | 2019 | 1668 | 0.270 |
Why?
|
Lipids | 4 | 2014 | 3341 | 0.240 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2015 | 162 | 0.230 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2008 | 1496 | 0.230 |
Why?
|
Choline | 8 | 2004 | 515 | 0.230 |
Why?
|
Energy Metabolism | 2 | 2024 | 2882 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 9000 | 0.220 |
Why?
|
Genomics | 2 | 2010 | 5821 | 0.210 |
Why?
|
Protons | 5 | 2008 | 1116 | 0.210 |
Why?
|
Macrophages | 2 | 2024 | 5769 | 0.210 |
Why?
|
Mice | 18 | 2024 | 81525 | 0.210 |
Why?
|
Paresis | 1 | 2023 | 176 | 0.200 |
Why?
|
Brain | 11 | 2013 | 27112 | 0.200 |
Why?
|
Animals | 23 | 2024 | 168459 | 0.200 |
Why?
|
Asphyxia Neonatorum | 1 | 2002 | 111 | 0.190 |
Why?
|
Hindlimb | 4 | 2008 | 513 | 0.190 |
Why?
|
Trans-Activators | 2 | 2008 | 2856 | 0.190 |
Why?
|
Gadolinium DTPA | 2 | 2002 | 823 | 0.180 |
Why?
|
Hand | 3 | 2019 | 902 | 0.180 |
Why?
|
Biopsy | 6 | 2016 | 6766 | 0.180 |
Why?
|
Artificial Intelligence | 2 | 2012 | 2578 | 0.180 |
Why?
|
Down-Regulation | 1 | 2008 | 2919 | 0.180 |
Why?
|
Blood Volume | 1 | 2002 | 547 | 0.180 |
Why?
|
Lactic Acid | 3 | 2004 | 1139 | 0.180 |
Why?
|
Central Nervous System Neoplasms | 2 | 2007 | 916 | 0.170 |
Why?
|
Glioblastoma | 3 | 2012 | 3482 | 0.170 |
Why?
|
Insulin | 2 | 2014 | 6596 | 0.170 |
Why?
|
Cerebrovascular Circulation | 2 | 2002 | 2727 | 0.170 |
Why?
|
Oxidative Phosphorylation | 3 | 2024 | 496 | 0.170 |
Why?
|
Magnetic Resonance Angiography | 2 | 2004 | 1432 | 0.160 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4915 | 0.160 |
Why?
|
Motor Activity | 1 | 2009 | 2715 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8547 | 0.160 |
Why?
|
Mice, Inbred Strains | 3 | 2010 | 1762 | 0.150 |
Why?
|
Body Surface Area | 2 | 2008 | 197 | 0.150 |
Why?
|
Brain Chemistry | 4 | 2004 | 960 | 0.140 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2010 | 557 | 0.140 |
Why?
|
Speech Perception | 1 | 2002 | 507 | 0.140 |
Why?
|
Spin Labels | 2 | 2008 | 337 | 0.140 |
Why?
|
Aging | 1 | 2015 | 8708 | 0.140 |
Why?
|
Carbohydrate Metabolism | 2 | 2009 | 263 | 0.140 |
Why?
|
Humans | 42 | 2024 | 761504 | 0.130 |
Why?
|
Arousal | 1 | 2002 | 1166 | 0.130 |
Why?
|
Reactive Oxygen Species | 3 | 2024 | 2141 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2008 | 11121 | 0.130 |
Why?
|
Algorithms | 4 | 2009 | 14031 | 0.130 |
Why?
|
Metabolome | 2 | 2014 | 989 | 0.130 |
Why?
|
Child | 17 | 2016 | 80153 | 0.120 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 295 | 0.120 |
Why?
|
Glioma | 3 | 2012 | 3455 | 0.120 |
Why?
|
Male | 30 | 2024 | 360804 | 0.120 |
Why?
|
Moyamoya Disease | 1 | 1997 | 265 | 0.110 |
Why?
|
Cerebellum | 2 | 2013 | 1501 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11903 | 0.110 |
Why?
|
Tetrazolium Salts | 1 | 2013 | 93 | 0.110 |
Why?
|
Amino Acids | 2 | 2010 | 1718 | 0.110 |
Why?
|
Inositol | 2 | 2010 | 215 | 0.110 |
Why?
|
Psychomotor Performance | 1 | 2002 | 1881 | 0.110 |
Why?
|
Motor Cortex | 2 | 2013 | 1006 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2013 | 2231 | 0.110 |
Why?
|
Aconitate Hydratase | 1 | 2013 | 17 | 0.110 |
Why?
|
Transcription Factors | 6 | 2024 | 12128 | 0.110 |
Why?
|
Neoplasms | 2 | 2013 | 22170 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2016 | 365 | 0.100 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2009 | 12795 | 0.100 |
Why?
|
Mutation | 2 | 2014 | 30052 | 0.100 |
Why?
|
Child, Preschool | 11 | 2009 | 42230 | 0.100 |
Why?
|
Infant | 10 | 2009 | 36192 | 0.100 |
Why?
|
Attention | 1 | 2002 | 2396 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 695 | 0.090 |
Why?
|
Signal Transduction | 2 | 2014 | 23445 | 0.090 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2019 | 542 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2010 | 6228 | 0.090 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3847 | 0.090 |
Why?
|
Reference Values | 2 | 2012 | 4920 | 0.090 |
Why?
|
Microarray Analysis | 1 | 2013 | 749 | 0.090 |
Why?
|
Adolescent | 12 | 2010 | 88319 | 0.090 |
Why?
|
Receptors, Glucagon | 1 | 2010 | 90 | 0.090 |
Why?
|
Databases, Factual | 1 | 2006 | 7967 | 0.090 |
Why?
|
Glutarates | 1 | 2012 | 243 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18252 | 0.090 |
Why?
|
Nerve Net | 1 | 2002 | 2290 | 0.090 |
Why?
|
PPAR delta | 1 | 2009 | 40 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2012 | 273 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1301 | 0.080 |
Why?
|
Central Nervous System Diseases | 1 | 1993 | 520 | 0.080 |
Why?
|
Random Allocation | 2 | 2010 | 2395 | 0.080 |
Why?
|
PPAR alpha | 1 | 2009 | 175 | 0.080 |
Why?
|
Phosphorus Isotopes | 1 | 2008 | 124 | 0.080 |
Why?
|
Fatty Acids | 2 | 2006 | 1808 | 0.080 |
Why?
|
Regression Analysis | 2 | 2008 | 6343 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2008 | 240 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22169 | 0.070 |
Why?
|
Astrocytoma | 1 | 2012 | 775 | 0.070 |
Why?
|
Muscular Atrophy | 1 | 2010 | 334 | 0.070 |
Why?
|
Chronic Disease | 2 | 2013 | 9318 | 0.070 |
Why?
|
Ischemia | 1 | 2016 | 1882 | 0.070 |
Why?
|
Models, Biological | 3 | 2008 | 9469 | 0.070 |
Why?
|
Prognosis | 4 | 2011 | 29625 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 1048 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2016 | 0.070 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7407 | 0.070 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2008 | 393 | 0.070 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2010 | 547 | 0.070 |
Why?
|
Logistic Models | 3 | 2011 | 13255 | 0.070 |
Why?
|
Drug Discovery | 1 | 2014 | 1051 | 0.070 |
Why?
|
Artificial Limbs | 1 | 2008 | 121 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1517 | 0.070 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2002 | 5777 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2008 | 20098 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 938 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
Phantoms, Imaging | 2 | 2012 | 2526 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 613 | 0.060 |
Why?
|
Electron Transport | 1 | 2005 | 210 | 0.060 |
Why?
|
Gluconeogenesis | 1 | 2005 | 185 | 0.060 |
Why?
|
Metabolomics | 1 | 2013 | 1659 | 0.060 |
Why?
|
Glycolysis | 1 | 2008 | 835 | 0.060 |
Why?
|
Radiography | 2 | 2013 | 6965 | 0.060 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2003 | 46 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2009 | 7594 | 0.050 |
Why?
|
Meningioma | 1 | 2012 | 1218 | 0.050 |
Why?
|
Cold Temperature | 1 | 2006 | 785 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2979 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1420 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14666 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.050 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2001 | 38 | 0.050 |
Why?
|
Phosphates | 1 | 2005 | 770 | 0.050 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2006 | 621 | 0.050 |
Why?
|
Prosthesis Design | 1 | 2008 | 2115 | 0.050 |
Why?
|
Models, Neurological | 1 | 2009 | 1767 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 623 | 0.040 |
Why?
|
Virulence Factors | 1 | 2024 | 513 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 1897 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2007 | 2707 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2496 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 819 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.040 |
Why?
|
Diffusion | 1 | 2002 | 814 | 0.040 |
Why?
|
Age Factors | 2 | 2010 | 18395 | 0.040 |
Why?
|
Epilepsy | 2 | 2012 | 3290 | 0.040 |
Why?
|
Creatine | 2 | 2004 | 427 | 0.040 |
Why?
|
Xanthine Oxidase | 1 | 2019 | 69 | 0.040 |
Why?
|
Female | 14 | 2012 | 392644 | 0.040 |
Why?
|
Lactates | 2 | 2000 | 405 | 0.040 |
Why?
|
Adult | 10 | 2012 | 221177 | 0.040 |
Why?
|
NADP | 1 | 2019 | 227 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2019 | 260 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10090 | 0.040 |
Why?
|
Neural Pathways | 1 | 2009 | 3058 | 0.040 |
Why?
|
Wakefulness | 1 | 2005 | 1265 | 0.040 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2001 | 352 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2898 | 0.040 |
Why?
|
Virulence | 2 | 2014 | 1303 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6240 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 1008 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5247 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2208 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4936 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6216 | 0.030 |
Why?
|
Angiogenic Proteins | 1 | 2016 | 101 | 0.030 |
Why?
|
Disease Progression | 2 | 2004 | 13506 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2303 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2000 | 852 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6346 | 0.030 |
Why?
|
Young Adult | 3 | 2012 | 59243 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 22176 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2019 | 1154 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12947 | 0.030 |
Why?
|
Gene Expression | 1 | 2006 | 7581 | 0.030 |
Why?
|
Drug Resistance, Multiple | 1 | 2014 | 255 | 0.030 |
Why?
|
Capillaries | 1 | 2016 | 755 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1068 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12463 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26125 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 871 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 855 | 0.020 |
Why?
|
Middle Aged | 4 | 2012 | 220895 | 0.020 |
Why?
|
Heart Arrest | 1 | 2001 | 1514 | 0.020 |
Why?
|
Extremities | 1 | 2016 | 867 | 0.020 |
Why?
|
Creatinine | 1 | 1996 | 1899 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2004 | 15266 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1486 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2003 | 26198 | 0.020 |
Why?
|
Virus Cultivation | 1 | 2007 | 88 | 0.020 |
Why?
|
Time Factors | 2 | 2006 | 39967 | 0.020 |
Why?
|
Hemodynamics | 1 | 1997 | 4159 | 0.020 |
Why?
|
Rheology | 1 | 2008 | 347 | 0.020 |
Why?
|
Brain Mapping | 1 | 2002 | 6630 | 0.020 |
Why?
|
Central Nervous System | 1 | 1993 | 1336 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8320 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2019 | 18965 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2002 | 9280 | 0.010 |
Why?
|
Hydrogen | 1 | 2003 | 172 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1993 | 2656 | 0.010 |
Why?
|
Quinolines | 1 | 2007 | 764 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2007 | 1133 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7396 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2007 | 64680 | 0.010 |
Why?
|
Phosphorylcholine | 1 | 2000 | 153 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1972 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 470 | 0.010 |
Why?
|
Gliosis | 1 | 2000 | 245 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2001 | 554 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5871 | 0.010 |
Why?
|
Cell Survival | 1 | 2007 | 5791 | 0.010 |
Why?
|
Resuscitation | 1 | 2001 | 673 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2001 | 1834 | 0.010 |
Why?
|
Brain Stem | 1 | 2001 | 858 | 0.010 |
Why?
|
Necrosis | 1 | 2000 | 1611 | 0.010 |
Why?
|
Thalamus | 1 | 2001 | 1045 | 0.010 |
Why?
|
Cholesterol | 1 | 2003 | 2904 | 0.010 |
Why?
|
Inflammation | 1 | 2006 | 10773 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15842 | 0.000 |
Why?
|
Aged | 1 | 2012 | 169289 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2003 | 80636 | 0.000 |
Why?
|